Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (250 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 21 Feb 2024 – 20 Aug 2026, limited by quant PSU Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant PSU Fund | Nifty 500 |
|---|---|---|
| 21 Feb 2024 | ₹100.00 | ₹100.00 |
| 07 May 2024 | ₹103.97 | ₹102.52 |
| 22 Jul 2024 | ₹125.29 | ₹113.98 |
| 06 Oct 2024 | ₹120.13 | ₹116.92 |
| 21 Dec 2024 | ₹103.51 | ₹110.89 |
| 07 Mar 2025 | ₹93.73 | ₹101.57 |
| 22 May 2025 | ₹103.90 | ₹112.25 |
| 05 Aug 2025 | ₹101.69 | ₹113.27 |
| 20 Oct 2025 | ₹104.90 | ₹117.82 |
| 04 Jan 2026 | ₹108.03 | ₹119.73 |
| 21 Mar 2026 | ₹95.96 | ₹105.96 |
| 05 Jun 2026 | ₹111.60 | ₹111.61 |
| 20 Aug 2026 | ₹108.75 | ₹116.82 |
| Metric | quant · Direct · IDCW NAV ₹10.87 Very High risk ★★★☆☆ 1Y | Category median Sectoral/ Thematic · 250 funds |
|---|---|---|
| +7.53% | +5.11% | |
| — | +13.02% | |
| — | +11.14% | |
| — | +12.26% | |
| +3.42% | +11.82% | |
| +1.89% | — | |
| — | +14.62% | |
| — | +12.95% | |
| — | +13.24% | |
| Risk | ||
| 22.71% | 15.88% | |
| 0.04 | 0.35 | |
| 0.06 | 0.47 | |
| -31.06% | -25.18% | |
| Nifty 500 | — | |
| -1.64% | +1.40% | |
| 1.39 | 0.98 | |
| 123.9% | 101.5% | |
| 149.1% | 97.0% | |
| 2.23% | 1.14% | |
| ₹485.56Cr | ₹1,162Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 45% | |
| Sandeep Tandon · 2.5y | — | |
| 21 Feb 2024 | — | |
| 10 | — | |
| 79.4% | — | |
| -3.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.